Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company manufactures solid oral drug delivery systems. It offers oral solid dosage solutions from tablets, capsules, DC granules, and pellets.
Inventia Healthcare Limited, is an unlisted public company incorporated on 27 September, 1985. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 25.00 cr and the total paid-up capital is INR 12.53 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
40.68%
82.92%
202.14%
18.97%
7.22%
14.58%
-4.44
4.93
5.45
10.74
15.39
-0.03
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(18)
| State | Type | Address |
|---|---|---|
| Maharashtra | Registered Office | Unit 703-704, 7th Floor. Solaris One Premises Co-operative S ociety Limited, N S Phadke Marg, Andher Mumbai Mumbai Maharashtra - 400069 |
| Maharashtra | Sales Office | 7th Floor, Unit 703 and 704, Solaris One Premises Co-op Society Ltd, NS Phadke Road, Andheri East, Mumbai, Mumbai Suburban, Maharashtra, 400069 |
| Maharashtra | Sales Office | A 214, Wagle Industrial Estate, Road No.30, Thane, Thane, Maharashtra, 400604 |
| Maharashtra | Sales Office | A-215, Wagle Industrial Estate, Road No.30, Thane, Thane, Maharashtra, 400604 |
| Maharashtra | Export, Sales Office, Import | F1, F1-1 and F-75/1, Additional Ambernath MIDC Area,, Village- Jambivali Taluka, Ambernath East, Thane, Maharashtra, 421506 |
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 3
Total Amount : 253.2 cr
DBS BANK INDIA LIMITED
No. of Loans: 1
Total Amount : 60.0 cr
Total Amount : 125.0 cr
Charge Date : 27 Jun, 2024
Total Amount : 125.0 cr
Charge Date : 27 Jun, 2024
Total Amount : 60.0 cr
Charge Date : 27 Jun, 2024
Total Amount : 3.2 cr
Charge Date : 02 Dec, 2023
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Whole-time Director | Ankur Janak Shah
Shareholder
|
01656781 | 3 years |
| Whole-time Director | Vishal Janak Shah
Shareholder
|
05349303 | 7 years |
| Director | Amit Sobti | 07795874 | 1 years |
| Director | Gregory Pak Hon Wong | 10671235 | 1 years |
| Director | Ju Hyun Lee | 10671238 | 1 years |
| CS | Rupa D Desai | <HIDDEN> | 15 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| INVENGENE BIOSCIENCES PRIVATE LIMITED |
Strike Off
|
5.0 L | 1 | Maharashtra |
| TPC ENTERPRISE PRIVATE LIMITED |
Active
|
2.0 L | 1 | Gujarat |
| INVENGENE LIMITED |
Active
|
1.5 Cr | 1 | Maharashtra |
| VA3 VENTURES LLP |
Active
|
50,000.0 | 1 | Maharashtra |
| INKNOWLEDGE DEVELOPMENT PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| NUTRIVENTIA LIMITED |
Active
|
9.0 Cr | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Nutriventia LLC | United States | - | - |
| Inventia Healthcare (UK) Limited | United Kingdom | - | - |
| NUTRIVENTIA LIMITED | Maharashtra | 2022 | ₹ 9.0 Cr |
| Inventia Healthcare FZ-LLC | Netherlands | - | - |
| Inventia Healthcare BV | Netherlands | - | - |
| INVENGENE LIMITED | Maharashtra | 2023 | ₹ 1.5 Cr |
The incorporation date of INVENTIA HEALTHCARE LIMITED is 27 September, 1985
The authorized share capital of INVENTIA HEALTHCARE LIMITED is INR ₹ 25.0 Cr.
The paid-up capital of INVENTIA HEALTHCARE LIMITED is INR ₹ 12.5 Cr.
The registered address of INVENTIA HEALTHCARE LIMITED is Unit 703-704, 7th Floor. Solaris One Premises Co-operative S ociety Limited, N S Phadke Marg, Andher Mumbai Mumbai Maharashtra - 400069
The CIN number of INVENTIA HEALTHCARE LIMITED is U24239MH1985PLC037597.
Expand
Delete
Collapse
See
details
